Quebec company to test blood cancer treatment

Wednesday 5 August 2009

Quebec City biotech company Aeterna Zentaris Inc. and partner-licensee Keryx Biopharmaceuticals Inc. of the U.S. said they are moving ahead with a late-stage study of perifosine, a treatment for multiple myeloma, a form of blood cancer.

>> http://www.montrealgazette.com/health/Quebec+company+test+blood+cancer+treatment/1855842/story.html


Further information

European Oncology Nursing Society
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu